Artiva BiotherapeuticsARTV
那斯達克 · USD
7.42
+0.15
(+2.06%)
收盤 06/11 03:59 (UTC+8)
06/11 03:59 (UTC+8)
Artiva BiotherapeuticsARTV
7.42
+0.15
(+2.06%)
財務數據
損益表
- 0.02
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -91.18
- -89.32
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | 251 | 2,350 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | 251 | 2,350 |
營業費用 | 24,430 | 21,932 | 22,896 | 22,811 | - | - | 18,334 | 16,189 | 14,743 | 14,320 |
研發費用 | 19,312 | 16,994 | 17,632 | 17,862 | 17,052 | 13,317 | 13,523 | 12,332 | 11,156 | 11,153 |
推銷及管理費用 | 5,118 | 4,938 | 5,264 | 4,949 | 5,119 | 4,950 | 4,811 | 3,857 | 3,587 | 3,167 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -24,430 | -21,932 | -22,896 | -22,811 | -22,171 | -18,267 | -18,334 | -16,189 | -14,492 | -11,970 |
其他收入及費用 | 914 | 1,160 | 1,368 | 1,557 | 1,860 | 2,172 | 862 | -1,654 | 529 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -23,516 | -20,772 | -21,528 | -21,254 | -20,311 | -16,095 | -17,472 | -17,843 | - | -10,902 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -23,516 | -20,772 | -21,528 | -21,254 | -20,311 | -16,095 | -17,472 | -17,843 | -13,963 | -10,974 |
基本每股稅後盈餘(元) | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 | -3.67 | -0.92 | -0.77 | -0.60 | - |
稀釋每股稅後盈餘(元) | -0.95 | -0.84 | -0.88 | -0.88 | -0.83 | 1.35 | 32.08 | -22.00 | -17.24 | - |
基本平均股數(千股) | 24678.00 | 24576.00 | 24481.00 | 24378.00 | 24341.00 | - | 18896.00 | 23281.00 | 23281.00 | - |
稀釋平均股數(千股) | 24678.00 | 24576.00 | 24481.00 | 24378.00 | 24341.00 | - | 18896.00 | 23281.00 | 23281.00 | - |
還原基本每股稅後盈餘(元) | -0.95 | -0.85 | -0.88 | -0.87 | -0.83 | -3.67 | -0.92 | -0.77 | -0.60 | - |
還原稀釋每股稅後盈餘(元) | -0.95 | -0.84 | -0.88 | -0.88 | -0.83 | 1.35 | 32.08 | -22.00 | -17.24 | - |
還原基本平均股數(千股) | 24,678 | 24,576 | 24,481 | 24,378 | 24,341 | - | 18,896 | 23,281 | 23,281 | - |
還原稀釋平均股數(千股) | 24,678 | 24,576 | 24,481 | 24,378 | 24,341 | - | 18,896 | 23,281 | 23,281 | - |
EBITDA(千元) | -23,049 | -20,397 | -21,223 | -21,122 | -20,406 | -16,523 | -17,504 | -17,513 | -13,744 | -10,380 |